➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Boehringer Ingelheim
McKinsey
Express Scripts
Moodys

Last Updated: November 30, 2020

DrugPatentWatch Database Preview

LANSOPRAZOLE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Lansoprazole, and when can generic versions of Lansoprazole launch?

Lansoprazole is a drug marketed by Ajanta Pharma Ltd, Alkem Labs Ltd, Breckenridge, Dr Reddys Labs Ltd, Hetero Labs Ltd Iii, Inventia, Krka Tovarna Zdravil, Lannett Co Inc, Mylan, Mylan Pharms Inc, Natco Pharma Ltd, Perrigo R And D, Sandoz, Sun Pharm, Teva Pharms, Wockhardt Ltd, Wockhardt Usa, Xiromed, Zydus Hlthcare, Ani Pharms Inc, Dexcel Pharma, Teva Pharms Usa, Zydus Pharms, Rising, and Sandoz Inc. and is included in thirty-one NDAs.

The generic ingredient in LANSOPRAZOLE is amoxicillin; clarithromycin; lansoprazole. There are forty-six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amoxicillin; clarithromycin; lansoprazole profile page.

Drug patent expirations by year for LANSOPRAZOLE
Drug Prices for LANSOPRAZOLE

See drug prices for LANSOPRAZOLE

Drug Sales Revenue Trends for LANSOPRAZOLE

See drug sales revenues for LANSOPRAZOLE

Recent Clinical Trials for LANSOPRAZOLE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Roma La SapienzaEarly Phase 1
Daewoong Pharmaceutical Co. LTD.Phase 3
PETHEMA FoundationPhase 3

See all LANSOPRAZOLE clinical trials

Pharmacology for LANSOPRAZOLE
Medical Subject Heading (MeSH) Categories for LANSOPRAZOLE
Paragraph IV (Patent) Challenges for LANSOPRAZOLE
Tradename Dosage Ingredient NDA Submissiondate
PREVACID TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL lansoprazole 021428 2006-12-27
PREVACID CAPSULE, DELAYED REL PELLETS;ORAL lansoprazole 020406 2005-12-05

US Patents and Regulatory Information for LANSOPRAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dexcel Pharma LANSOPRAZOLE lansoprazole TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL 208025-001 Jun 7, 2016 OTC No No   Start Trial   Start Trial   Start Trial
Wockhardt Ltd LANSOPRAZOLE lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 202727-001 May 18, 2012 OTC No No   Start Trial   Start Trial   Start Trial
Rising LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN amoxicillin; clarithromycin; lansoprazole CAPSULE, CAPSULE, DELAYED REL PELLETS, TABLET;ORAL 206006-001 Oct 7, 2016 AB RX No Yes   Start Trial   Start Trial   Start Trial
Teva Pharms Usa LANSOPRAZOLE lansoprazole TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL 208784-002 Sep 21, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Sandoz Inc LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN amoxicillin; clarithromycin; lansoprazole CAPSULE, CAPSULE, DELAYED REL PELLETS, TABLET;ORAL 202588-001 Mar 4, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm LANSOPRAZOLE lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 202637-001 Sep 13, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Johnson and Johnson
Express Scripts
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.